Plain-English translation of NCT06855069 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help women with ovarian cancer that has come back and stopped responding to platinum-based chemotherapy. You would be randomly assigned to either receive or a standard chemotherapy chosen by your doctor. The trial will compare how well each treatment works and how safe it is.
Ovarian cancer that returns after platinum treatment is very difficult to manage, and current options have limited success. This trial is investigating whether the new treatment might offer better results with a different approach for women in this challenging situation.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to either receive or your doctor's chosen standard chemotherapy. The trial will involve regular clinic visits to receive treatment, have blood tests, and have imaging scans to see how your cancer is responding. Your doctor will monitor you closely for any side effects or changes in your health throughout the study.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China